Wirth is the CEO of Amida Care. Crowley is the director of the O’Neill Institute’s Center for HIV and Infectious Disease Policy at Georgetown Law. In June, a clinical trial showed that a twice-yearly ...

The US Preventive Services Task Force (USPSTF) announced its recommendation for HIV pre-exposure prophylaxis (PrEP). The US Preventive Services Task Force (USPSTF) granted an “A” grade for HIV ...

The nation’s ability to prevent HIV was dealt a hard blow early in the COVID-19 pandemic, according to a new CDC analysis published today, on World AIDS Day: Putting Ourselves to the Test: Achieving ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A brand new drug might be more effective at preventing HIV than current ...

The US Preventive Services Task Force recently issued a recommendation statement for preexposure prophylaxis (PrEP) for HIV, but it is so broadly worded that it will be subject to vast payer ...

For the first time, an HIV PrEP drug candidate has shown zero infections in a phase 3 trial. The result came from the PURPOSE 1 trial evaluating Gilead Sciences’ twice-yearly, subcutaneous lenacapavir ...

Applying novel and effective approaches based on behavioral economics for pre-exposure prophylaxis (PrEP) dissemination programs could help to tailor the programs to the populations and settings of ...

Science progresses when people share what they learn, not when they retreat behind borders or institutions. That was true when my colleagues and I first discovered a protein, known today as ...